Immunofluorescence analysis of TNF-α and IL-6 expression in COPD mouse model revealed bright expression in the COPD group, with varying degrees of attenuation in each group following HPMHD treatment (Figures 6, 7). This evidence concerns the gene IL6 and chronic obstructive pulmonary disease.